AGAPE ATP CORPORATION Financing Cash Flow
AGAPE ATP CORPORATION (ATPC) reported Financing Cash Flow of $414.05 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-14
- AGAPE ATP CORPORATION net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$82.43K, a 168.11% decline year-over-year.
- AGAPE ATP CORPORATION net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $496.47K, a 97.84% decline year-over-year.
- AGAPE ATP CORPORATION net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $201.64K.
- AGAPE ATP CORPORATION net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $181.33K.
- AGAPE ATP CORPORATION net cash provided by (used in) financing activities for fiscal 2025 was $23.50M.
- AGAPE ATP CORPORATION net cash provided by (used in) financing activities for fiscal 2024 was -$11.86K, a 100.22% decline from fiscal 2023.
- AGAPE ATP CORPORATION net cash provided by (used in) financing activities for fiscal 2023 was $5.40M.
- AGAPE ATP CORPORATION net cash provided by (used in) financing activities for fiscal 2022 was -$234.47K.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$82.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $414.05K 10-Q · filed 2026-08-14 | $615.68K derived: sum of 3 quarters · filed 2026-08-14 | $797.01K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $496.47K 10-Q · filed 2026-05-15 | $698.11K derived: sum of 2 quarters · filed 2026-05-15 | $879.44K derived: sum of 3 quarters · filed 2026-05-15 | $1.00M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $201.64K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $382.97K derived: sum of 2 quarters · filed 2026-04-13 | $503.99K derived: sum of 3 quarters · filed 2026-08-14 | $23.50M 10-K · filed 2026-04-13 | |
| 2025-09-30 | $181.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $302.35K derived: sum of 2 quarters · filed 2026-08-14 | $23.30M 10-Q · filed 2025-11-13 | $23.29M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $121.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $23.12M 10-Q · filed 2026-08-14 | $23.11M derived: sum of 3 quarters · filed 2026-08-14 | $23.11M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $22.99M 10-Q · filed 2026-05-15 | $22.99M derived: sum of 2 quarters · filed 2026-05-15 | $22.99M derived: sum of 3 quarters · filed 2026-05-15 | $22.98M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$5.17K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | -$9.01K derived: sum of 2 quarters · filed 2026-04-13 | -$10.96K derived: sum of 3 quarters · filed 2026-04-13 | -$11.86K 10-K · filed 2026-04-13 | |
| 2024-09-30 | -$3.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$5.79K derived: sum of 2 quarters · filed 2025-11-13 | -$6.69K 10-Q · filed 2025-11-13 | $5.51M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | -$1.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$2.85K 10-Q · filed 2025-08-13 | $5.51M derived: sum of 3 quarters · filed 2025-08-13 | $5.42M derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | -$899.00 10-Q · filed 2025-05-15 | $5.51M derived: sum of 2 quarters · filed 2025-05-15 | $5.42M derived: sum of 3 quarters · filed 2025-05-15 | $5.40M derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $5.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $5.42M derived: sum of 2 quarters · filed 2025-03-31 | $5.40M derived: sum of 3 quarters · filed 2025-03-31 | $5.40M 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$91.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$106.95K derived: sum of 2 quarters · filed 2024-11-14 | -$113.91K 10-Q · filed 2024-11-14 | -$163.91K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | -$15.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$22.86K 10-Q · filed 2024-08-14 | -$72.86K derived: sum of 3 quarters · filed 2024-08-14 | -$78.40K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | -$6.96K 10-Q · filed 2024-05-14 | -$56.96K derived: sum of 2 quarters · filed 2024-05-14 | -$62.50K derived: sum of 3 quarters · filed 2024-05-14 | ||
| 2022-12-31 | -$50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$55.54K derived: sum of 2 quarters · filed 2024-04-01 | -$234.47K 10-K · filed 2024-04-01 | ||
| 2022-09-30 | -$5.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$184.47K 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | -$178.93K 10-Q · filed 2023-08-14 | ||||
| 2021-12-31 | $4.22K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$2.47K derived: sum of 2 quarters · filed 2023-03-31 | -$12.64K derived: sum of 3 quarters · filed 2023-03-31 | -$19.06K 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$6.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$16.86K derived: sum of 2 quarters · filed 2022-11-14 | -$23.28K 10-Q · filed 2022-11-14 | -$66.47K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$10.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$16.59K 10-Q · filed 2022-08-11 | -$59.78K derived: sum of 3 quarters · filed 2022-08-11 | -$179.52K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$6.42K 10-Q · filed 2022-05-13 | -$49.62K derived: sum of 2 quarters · filed 2022-07-05 | -$169.35K derived: sum of 3 quarters · filed 2022-07-05 | ||
| 2020-12-31 | -$43.20K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2022-07-05 | -$162.93K derived: sum of 2 quarters · filed 2022-07-05 | -$22.09K 10-K/A · filed 2022-07-05 | ||
| 2020-09-30 | -$119.73K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-07-05 | $21.10K 10-Q/A · filed 2022-07-05 | |||
| 2020-06-30 | $140.84K 10-Q · filed 2021-08-13 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $0.00 derived: sum of 2 quarters · filed 2021-03-31 | -$4.57K 10-K · filed 2021-03-31 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$4.57K 10-Q · filed 2020-11-16 | |||
| 2019-06-30 | -$4.57K 10-Q · filed 2020-08-13 | -$5.32K 10-K · filed 2020-03-27 | |||
| 2018-12-31 | -$745.00 10-K · filed 2020-03-27 | -$1.00K 10-Q · filed 2019-02-15 | |||
| 2018-06-30 | $4.77K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $2.50M derived: sum of 2 quarters · filed 2020-03-27 | $2.93M 10-K · filed 2020-03-27 | ||
| 2018-03-31 | $2.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-13 | $2.93M 10-Q · filed 2019-05-13 | |||
| 2017-12-31 | $434.50K 10-Q · filed 2019-02-15 | ||||
| 2017-06-30 | $2.41M 10-K · filed 2018-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |